Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Columbia Threadneedle

VY(R) Columbia Small Cap Value and Inflection Portfolio CLASS S (ICSSX)

Ticker ICSSX · Since 2006-05-01 · · Holdings as of Jun 30, 2026

Expense ratio
1.18%$118/yr per $10k
5-yr return
+9.6%annualized
1-yr return
+8.0%as of Dec 2025
Net assets
$75.0Mall share classes
Holdings
103

Bottom line

Is ICSSX a good fund? The bottom line

ICSSX is the CLASS S share class of VY(R) Columbia Small Cap Value and Inflection Portfolio, a managed small-cap mutual fund from Columbia Threadneedle.

It charges 1.18% — about $118 a year on every $10,000 invested, more expensive than 68% of small-cap funds we track.

It returned +8.0% over one year, +9.6% a year over five years, +8.9% a year over ten (as of Dec 31, 2025, per its prospectus).

With $75.0 million in net assets and 103 holdings, its largest position is Phillips Edison & Company Inc (2.0%) and the top 10 make up 16.7% of the portfolio.

What stands out

  • 5-year return beat 78% of category peers

What to watch

  • 12b-1 marketing fee of 0.25% a year
  • High turnover (114% a year) can mean more taxable distributions

Updated Nov 19, 2026

What ICSSX invests in

The Portfolio seeks long-term growth of capital.

Under normal circumstances, the Portfolio invests at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in equity securities of companies that have market capitalizations in the range of the companies within the Russell 2000 Value Index (the Index) (which measures the performance of the small-cap value segment of the U.S. equity universe), at the time of purchase, that the sub-adviser (the Sub-Adviser) believes are undervalued and have the potential for long-term growth. The market capitalization range and composition of companies in the Index are subject to change. As such, the size of the companies in which the Portfolio invests may change. The Portfolio determines a company s market capitalization at the time of investment . The Portfolio may continue to hold a security as part of its 80% policy even if the companys market capitalization grows…

From the fund's prospectus (filed Apr 27, 2026).

ICSSX performance

Average annual total returns
1 yr5 yr10 yr
ICSSX+8.0%+9.6%+8.9%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full ICSSX performance history →

What ICSSX costs

On a $10,000 investment, ICSSX's 1.18% expense ratio costs about $118 a year. The prospectus estimates $1,578 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full ICSSX fee table →

ICSSX top 10 holdings

#Holding% of fund
1Phillips Edison & Company Inc PECO2.00%
2Amneal Pharmaceuticals Inc AMRX1.84%
3Fulton Financial Corp FULT1.70%
4Associated Banc-corp ASB1.64%
5Polaris Inc PII1.62%
6Texas Capital Bancshares Inc TCBI1.62%
7Essent Group Ltd ESNT1.60%
8Reynolds Consumer Products Inc REYN1.57%
9Openlane Inc OPLN1.55%
10Bankunited Inc BKU1.53%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 16.7% of the fund. See all top 25 holdings and asset mix →

Alternatives to ICSSX

More funds like ICSSX →

ICSSX FAQ

What is the expense ratio of ICSSX?
ICSSX's expense ratio is 1.18%, which works out to about $118 a year for every $10,000 invested. The prospectus estimates total costs of $1,578 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is ICSSX a good investment?
It depends on your goals, but the data points to: 5-year return beat 78% of category peers; 12b-1 marketing fee of 0.25% a year; high turnover (114% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does ICSSX hold?
ICSSX's largest holdings are Phillips Edison & Company Inc (2.0%), Amneal Pharmaceuticals Inc (1.8%), Fulton Financial Corp (1.7%), Associated Banc-corp (1.6%), Polaris Inc (1.6%). It holds 103 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is ICSSX's 5-year return?
ICSSX returned +9.6% a year over the five years ending Dec 31, 2025, and +8.9% a year over ten years. Past performance does not guarantee future results.
Who manages ICSSX?
ICSSX is offered by Columbia Threadneedle through Voya PARTNERS INC.